Compound ID | 445
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | SC-004 is the prodrug of SC-002. SC-002 has broad spectrum activity an against tested strains of MRSA, MSSA, S. pneumoniae, E. faecallis, E. coli, K. pneumoniae, P mirabilis, M. morganii and H. influenzae demonstrated better or similar activity when compared to cefdinir, cefaclor and cefixime. |
| Institute where first reported: | Taisho Pharmaceuticals, Japan |
| Year first mentioned: | 1992 |
| Highest developmental phase: | Phase 1 |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|